Fi-Med software helps identify drug test billing noncompliance

Healthcare organizations can help prevent drug testing noncompliance by implementing risk-based auditing software solutions, according to Brookfield, Wis.-based Fi-Med Management.

The revenue cycle management, subscription analytics and chronic care management services provider said healthcare professionals struggle to keep up with changing rules and regulations governing drug test billing, which can result in large fines.

But Fi-Med argues there are solutions, such as its tool REVEAL/md, to track and identify noncompliant healthcare providers prior to audits.

"The rules surrounding how providers and healthcare systems bill for drug testing are complicated, and it's easy to overbill. Even if the overbilling is accidental, the liability to an individual or healthcare organization is greatly increased — the insurance industry views overbilling as a type of fraud, and many organizations have already been sued for millions of dollars," said Adrian Velasquez, president, CEO and co-founder of Fi-Med. "One of the best ways that providers and healthcare institutions can protect themselves is by incorporating risk-based auditing software into their electronic health records systems to help identify compliance issues before audits can occur."

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.